Systematic literature review of health-related quality of life in locally-advanced non-small cell lung cancer: has it yet become state-of-the-art?

Lung cancer is the most common cause of cancer death globally (Ferlay et al., 2015). Currently, non-small cell lung cancer accounts for more than 80% of all lung cancers, of which the vast majority presents with advanced disease stages and 30 –35% has locally-advanced disease (LA-NSCLC) at diagnosis. Choosing the optimal treatment for these patients is difficult because of the large heterogeneity in disease extend and pathology, as well as in co-morbidity and general condition of each individual patient (Stinchcombe and Socinski, 2009) .

Source: Critical Reviews in Oncology Hematology - September 27, 2017 Category: Cancer & Oncology Authors: Lotte van der Weijst, Veerle Surmont, Wim Schrauwen, Yolande Lievens Tags: Oncology reviews Source Type: research